Cargando…
Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies
BACKGROUND: FDA-required labeling summarizes certain data that the FDA relies on in its drug approval process. However, when determining coverage of specialty drugs, health care payers may consider dissimilar evidence. OBJECTIVE: To compare evidence cited by the largest U.S. commercial payers in the...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397693/ https://www.ncbi.nlm.nih.gov/pubmed/30479201 http://dx.doi.org/10.18553/jmcp.2018.24.12.1240 |